Previous studies have showed that men suffering from diabetes mellitus, metabolic syndrome （MetS） and obesity have a higher risk of benign prostatic hyperplasia （BPH）. The present study aimed to examine the associ...Previous studies have showed that men suffering from diabetes mellitus, metabolic syndrome （MetS） and obesity have a higher risk of benign prostatic hyperplasia （BPH）. The present study aimed to examine the association between BPH, obesity, and features of MetS among men of the Hunan area of China. For this cross-sectional study, 904 males （aged 50-59 years） were included. MetS parameters, International Prostate Symptom Score （IPSS）, prostate-specific antigen （PSA） levels, total prostate volume （TPV）, postvoid residual volume （PVR） and maximum urine flow rate （Qmax） were measured. Results showed that MetS was associated with TPV （P = 0.048）, PVR （P = 0.004） and IPSS （P = 0.011）, but not with other indicators of BPH progression such as PSA levels or Qmax. MetS was associated with the voiding symptoms score （P〈 0.05）, but not with the storage symptom score. In addition, body mass index and fasting blood glucose positively correlated with TPV （r= 0.416, P〈 0.001; and r= 0.310, P= 0.011, respectively）. In conclusion, results suggest that MetS is associated with higher prostatic volume, prostate symptom score and voiding symptoms, but not with other features of prostatic hyperplasia such as PSA levels or Qmax. Changes in lifestyle factors, including physical activity and prevention of MetS, might be useful to prevent BPH and its progression, but further studies are needed.展开更多
文摘Previous studies have showed that men suffering from diabetes mellitus, metabolic syndrome （MetS） and obesity have a higher risk of benign prostatic hyperplasia （BPH）. The present study aimed to examine the association between BPH, obesity, and features of MetS among men of the Hunan area of China. For this cross-sectional study, 904 males （aged 50-59 years） were included. MetS parameters, International Prostate Symptom Score （IPSS）, prostate-specific antigen （PSA） levels, total prostate volume （TPV）, postvoid residual volume （PVR） and maximum urine flow rate （Qmax） were measured. Results showed that MetS was associated with TPV （P = 0.048）, PVR （P = 0.004） and IPSS （P = 0.011）, but not with other indicators of BPH progression such as PSA levels or Qmax. MetS was associated with the voiding symptoms score （P〈 0.05）, but not with the storage symptom score. In addition, body mass index and fasting blood glucose positively correlated with TPV （r= 0.416, P〈 0.001; and r= 0.310, P= 0.011, respectively）. In conclusion, results suggest that MetS is associated with higher prostatic volume, prostate symptom score and voiding symptoms, but not with other features of prostatic hyperplasia such as PSA levels or Qmax. Changes in lifestyle factors, including physical activity and prevention of MetS, might be useful to prevent BPH and its progression, but further studies are needed.
